Repligen

Repligen sees $150M Avitide acquisition as key to reaching gene therapy goals
MedCity News
Mon, 09/20/21 - 12:06 am
Repligen
Avitide
biologics
M&A
Repligen Signals Gene Therapy Strength With 2019 Earnings Report
Motley Fool
Fri, 02/21/20 - 11:39 pm
Repligen
earnings
gene therapy
Repligen reports 4Q loss
Yahoo/AP
Fri, 03/13/15 - 09:17 am
Repligen
earnings
Pfizer backs out of development deal with Repligen
Seeking Alpha
Fri, 01/30/15 - 01:18 pm
Pfizer
Repligen
SMA
spinal muscular atrophy
Most Popular News Headlines For Friday/Saturday August 15-16 2014
CP Wire
Mon, 08/18/14 - 11:48 am
Pfizer
FDA
Eisai
Amgen
Gilead
Sovaldi
Roche
DEA
Repligen
drug manufacturing
Most popular news headlines for Friday/Saturday August 15-16 2014
Mon, 08/18/14 - 11:47 am
Pfizer
FDA
Eisai
Amgen
Gilead
Sovaldi
Roche
DEA
Repligen
drug manufacturing
Amgen in talks with Repligen to equip 'facility of the future'
Bio-Pharma Reporter
Fri, 08/15/14 - 05:55 am
drug manufacturing
Amgen
Repligen
Repligen: A Strong Investment For The Right Kind Of Investor
Seeking Alpha
Sun, 05/4/14 - 11:36 am
Repligen
This Week in Biotech: Clinical Success, Plus Wheeling and Dealing
Motley Fool
Sun, 01/26/14 - 10:46 am
BioDelivery Sciences
Endo Health Solutions
Karyopharm Therapeutics
Repligen
Biomarin
Ariad Pharmaceuticals
Eli Lilly
GSK
Shire
Apples To Apples: Organovo Vs. Repligen
Seeking Alpha
Mon, 01/20/14 - 02:46 pm
Organovo
Repligen
bio-ink
Orencia
3 Important Catalysts That Fueled Repligen in 2013
Motley Fool
Thu, 12/12/13 - 08:42 am
Repligen
Orencia
Bristol-Myers Squibb
monoclonal antibodies
Repligen - My Projections For The Income Statement: 2013-2019
Seeking Alpha
Mon, 11/25/13 - 10:34 am
Repligen
What the End of Bristol-Myers Squibb Royalties Means for Repligen
Motley Fool
Sat, 11/16/13 - 01:26 pm
Bristol-Myers Squibb
Repligen
What the End of Bristol-Myers Squibb Royalties Means for Repligen
Motley Fool
Fri, 11/15/13 - 11:51 am
Repligen
Bristol-Myers Squibb
Orencia
Meet the Tiny Biotech Challenging Amgen and General Electric
Motley Fool
Tue, 11/5/13 - 08:08 am
Amgen
Repligen
General Electric
Repligen's CEO Discusses Q1 2013 Results - Earnings Call Transcript
Seeking Alpha
Sat, 05/4/13 - 10:33 am
Repligen
earnings
3 Ways Big Pharma Is Seizing This Rare Opportunity
Motley Fool
Fri, 04/5/13 - 10:21 am
Merck
Endocyte
Eli Lilly
Pfizer
Repligen
AbbVie
Protalix BioTherapeutics
Repligen Promises To Be A Cash Flow Machine
Seeking Alpha
Wed, 04/3/13 - 10:53 am
Repligen
Repligen forms partnership on spinal muscle drug
Yahoo/AP
Thu, 01/3/13 - 03:45 pm
Repligen
Spinal
Drug
Pfizer
Repligen will work with Pfizer to develop drug to treat for Spinal Muscular Atrophy
Yahoo/AP
Thu, 01/3/13 - 11:41 am
Pfizer
Repligen
spinal muscular atrophy

Pages